<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN">
<html>

<!-- Mirrored from www.naturesbounty.com/vf/healthnotes/HN_Live/Spanish/Es-Concern/Cardiomyopathy.ref.htm by HTTrack Website Copier/3.x [XR&CO'2005], Thu, 03 Mar 2005 14:30:34 GMT -->
<head>
<meta http-equiv="Content-Type" content="text/html; charset=ISO-8859-1">
<meta name="Language" content="es">
<meta name="ContentID" content="1183002">
<meta name="Category" content="Concern">
<meta name="Article" content="Cardiomyopathy">
<title>Cardiomiopat&#237;a-Referencias</title>
<link type="text/css" rel="stylesheet" href="../Styles/hnqrHtml.css">
<base target="_self">
</head>
<body>
<div id="Article-Title" class="Article-Title"><a name="Article-Title"></a> 

<p class="Article-Title">Cardiomiopat&#237;a</p>
</div>

<div id="Reference-List" class="Reference-List">
<p class="Reference-Autofill"><a href="Cardiomyopathy.htm">Volver al
art&#237;culo.</a></p>

<h3>Referencias para el art&#237;culo</h3>

<ol class="Reference-List">
<li class="Ref">Beers MH and Berkow R, eds. <em>The Merck Manual</em>, 17th ed. Whitehouse
Station, NJ: Merck and Co., Inc., 1999, 1692.</li>

<li class="Ref">Coughlin SS, Pearle DL, Baughman KL, et al. Diabetes mellitus and risk of
idiopathic dilated cardiomyopathy. The Washington, DC Dilated Cardiomyopathy Study. <em>Ann
Epidemiol</em> 1994;4(1):67&#8211;74.</li>

<li class="Ref">Post WS, Larson MG, Levy D. Hemodynamic predictors of incident hypertension.
The Framingham Heart Study. <em>Hypertension</em> 1994;24(5):585&#8211;90.</li>

<li class="Ref">McKenna CJ, Codd MB, McCann HA, Sugrue DD. Alcohol consumption and idiopathic
dilated cardiomyopathy: a case control study. <em>Am Heart J</em> 1998;135(5 Pt
1):833&#8211;7.</li>

<li class="Ref">Hoyumpa AM. Mechanisms of vitamin deficiencies in alcoholism. <em>Alcohol Clin
Exp Res</em> 1986;10(6):573&#8211;81.</li>

<li class="Ref">Lieber CS. Alcohol-nutrition interaction: 1984 update. <em>Alcohol</em>
1984;1(2):151&#8211;7.</li>

<li class="Ref">Klatsky AL. The cardiovascular effects of alcohol. <em>Alcohol</em> 1987;Suppl
1:117&#8211;24.</li>

<li class="Ref">Friedman HS. Cardiovascular effects of alcohol with particular reference to
the heart. <em>Alcohol</em> 1984;1(4):333&#8211;9.</li>

<li class="Ref">Urbano-Marquez A, Estruch R, Fernandez-Sola J, et al. The greater risk of
alcoholic cardiomyopathy and myopathy in women compared with men. <em>JAMA</em>
1995;274(2):149&#8211;54.</li>

<li class="Ref">Valgaeren G, Conraads V, Colpaert C, et al. Sudden death in hypertrophic
cardiomyopathy: risk stratification and prevention. <em>Acta Cardiol</em>
1998;53(1):23&#8211;9.</li>

<li class="Ref">Belardinelli R, Georgiou D, Cianci G, et al. Effects of exercise training on
left ventricular filling at rest and during exercise in patients with ischemic cardiomyopathy
and severe left ventricular systolic dysfunction. <em>Am Heart J</em> 1996;132(1 Pt
1):61&#8211;70.</li>

<li class="Ref">Belardinelli R, Georgiou D, Cianci G, et al. Exercise training improves left
ventricular diastolic filling in patients with dilated cardiomyopathy. Clinical and prognostic
implications. <em>Circulation</em> 1995;91(11):2775&#8211;84.</li>

<li class="Ref">Wielenga RP, Erdman RA, Huisveld IA, et al. Effect of exercise training on
quality of life in patients with chronic heart failure. <em>J Psychosom Res</em>
1998;45(5):459&#8211;64.</li>

<li class="Ref">Hambrecht R, Fiehn E, Weigl C, et al. Regular physical exercise corrects
endothelial dysfunction and improves exercise capacity in patients with chronic heart failure.
<em>Circulation</em> 1998;98(24):2709&#8211;15.</li>

<li class="Ref">Coughlin SS, Neaton JD, Sengupta A, Kuller LH. Predictors of mortality from
idiopathic dilated cardiomyopathy in 356,222 men screened for the Multiple Risk Factor
Intervention Trial<em>. Am J Epidemiol</em> 1994;139(2):166&#8211;72.</li>

<li class="Ref">Hartz AJ, Ratner ER, Sinoway LI, Bartholomew MJ. Smoking and idiopathic
congestive cardiomyopathy. <em>Jpn Heart J</em> 1996;37(3):401&#8211;7.</li>

<li class="Ref">Juilliere Y, Danchin N, Briancon S, et al. Dilated cardiomyopathy: long-term
follow-up and predictors of survival. <em>Int J Cardiol</em> 1988;21(3):269&#8211;77.</li>

<li class="Ref">Metayer C, Coughlin SS, Mather FJ. Does cigarette smoking paradoxically
increase survival in idiopathic dilated cardiomyopathy? The Washington, D.C., Dilated
Cardiomyopathy Study. <em>Cardiology</em> 1996;87(6):502&#8211;8.</li>

<li class="Ref">Manzoli U, Rossi E, Littarru GP, et al. Coenzyme Q10 in dilated
cardiomyopathy. <em>Int J Tissue React</em> 1990;12(3):173&#8211;8.</li>

<li class="Ref">Pogessi L, Galanti G, Comeglio M, et al. Effect of coenzyme Q10 on left
ventricular function in patients with dilative cardiomyopathy. <em>Curr Ther Res</em>
1991;49:878&#8211;86.</li>

<li class="Ref">Langsjoen PH, Vadhanavikit S, Folkers K. Response of patients in classes III
and IV of cardiomyopathy to therapy in a blind and crossover trial with coenzyme Q10. <em>Proc
Natl Acad Sci U S A</em> 1985;82:4240&#8211;4.</li>

<li class="Ref">Ma A, Zhang W, Liu Z. Effect of protection and repair of injury of
mitochondrial membrane-phospholipid on prognosis in patients with dilated cardiomyopathy. <em>
Blood Press Suppl</em> 1996;3:53&#8211;5.</li>

<li class="Ref">Belardinelli R, Georgiou D, Cianci G, et al. Effects of exercise training on
left ventricular filling at rest and during exercise in patients with ischemic cardiomyopathy
and severe left ventricular systolic dysfunction. <em>Am Heart J</em> 1996;132(1 Pt
1):61&#8211;70.</li>

<li class="Ref">Bresolin N, Doriguzzi C, Ponzetto C, et al. Ubidecarenone in the treatment of
mitochondrial myopathies: a multi-center double-blind trial. <em>J Neurol Sci</em>
1990;100:70&#8211;8.</li>

<li class="Ref">Permanetter B, Rossey W, Weingartner F, et al. Lack of effectiveness of
coenzyme Q10 (Ubiquinone) in long-term treatment of dilated cardiomyopathy. <em>Z Kardiol</em>
1989;78:360&#8211;5 [in German].</li>

<li class="Ref">Paulson DJ. Carnitine deficiency-induced cardiomyopathy. <em>Mol Cell
Biochem</em> 1998;180(1&#8211;2):33&#8211;41.</li>

<li class="Ref">Winter S, Jue K, Prochazka J, et al. The role of L-carnitine in pediatric
cardiomyopathy. <em>J Child Neurol</em> 1995;10 Suppl 2:S45&#8211;51.</li>

<li class="Ref">Kothari SS, Sharma M. L-carnitine in children with idiopathic dilated
cardiomyopathy. <em>Indian Heart J</em> 1998;50:59&#8211;61.</li>

<li class="Ref">Kittleson MD, Keene B, Pion PD, Loyer CG. Results of the multicenter spaniel
trial (MUST): taurine- and carnitine-responsive dilated cardiomyopathy in American cocker
spaniels with decreased plasma taurine concentration. <em>J Vet Intern Med</em>
1997;11:204&#8211;11.</li>

<li class="Ref">Pion PD, Kittleson MD, Thomas WP, et al. Response of cats with dilated
cardiomyopathy to taurine supplementation. <em>J Am Vet Med Assoc</em>
1992;201:275&#8211;84.</li>

<li class="Ref">Auzepy P, Blondeau M, Richard C, et al. Serum selenium deficiency in
myocardial infarction and congestive cardiomyopathy. <em>Acta Cardiol</em>
1987;42:161&#8211;6.</li>

<li class="Ref">Oster O, Prellwitz W, Kasper W, Meinertz T. Congestive cardiomyopathy and the
selenium content of serum. <em>Clin Chim Acta</em> 1983;29(128):125&#8211;32.</li>

<li class="Ref">Xu GL, Wang SC, Gu BQ, et al. Further investigation on the role of selenium
deficiency in the aetiology and pathogenesis of Keshan disease. <em>Biomed Environ Sci</em>
1997;10:316&#8211;26.</li>

<li class="Ref">Neve J. Selenium as a risk factor for cardiovascular diseases. <em>J
Cardiovasc Risk</em> 1996;3:42&#8211;7.</li>

<li class="Ref">Collipp PJ, Chen SY. Cardiomyopathy and selenium deficiency in a two-year-old
girl. <em>N Engl J Med</em> 1981;304:1304&#8211;5 [letter].</li>

<li class="Ref">Raines DA, Kinsara AJ, Eid Fawzy M, et al. Plasma and urinary selenium in
Saudi Arabian patients with dilated cardiomyopathy. <em>Biol Trace Elem Res</em>
1999;69:59&#8211;68.</li>

<li class="Ref">Ikram H, Crozier IG, Webster M, Low CJ. The role of selenium deficiency in
occidental dilated cardiomyopathy. <em>N Z Med J</em> 1989;102:100&#8211;2.</li>

<li class="Ref">Chou HT, Yang HL, Tsou SS,et al. Status of trace elements in patients with
idiopathic dilated cardiomyopathy in central Taiwan. <em>Chung Hua I Hsueh Tsa Chih
(Taipei)</em> 1998;61:193&#8211;8.</li>

<li class="Ref">Weikl A, Assmus KD, Neukum-Schmidt A, et al. Crataegus Special Extract WS
1442. Assessment of objective effectiveness in patients with heart failure. <em>Fortschr
Med</em> 1996;114:291&#8211;6 [in German].</li>

<li class="Ref">Weihmayr T, Ernst E. Therapeutic effectiveness of Crataegus. <em>Fortschr
Med</em> 1996;114:27&#8211;9 [in German].</li>

<li class="Ref">Leuchtgens H. Crataegus Special Extract WS 1442 in NYHA II heart failure. A
placebo controlled randomized double-blind study. <em>Fortschr Med</em> 1993;111:352&#8211;4
[in German].</li>

<li class="Ref">Dwivedi S, Jauhari R. Beneficial effects of Terminalia arjuna in coronary
artery disease. <em>Indian Heart J</em> 1997;49:507&#8211;10.</li>

<li class="Ref">Bharani A, Ganguly A, Bhargava KD. Salutary effect of Terminalia Arjuna in
patients with severe refractory heart failure. <em>Int J Cardiol</em>
1995;49:191&#8211;9.</li>

<li class="Ref">Lindner E, Dohadwalla AN, Bhattacharya BK. Positive inotropic and blood
pressure lowering activity of a diterpene derivative isolated from Coleus forskohli:
forskolin. <em>Arzneimittelforschung</em> 1978;28:284&#8211;9.</li>

<li class="Ref">Baumann G, Felix S, Sattelberger U, Klein G. Cardiovascular effects of
forskolin (HL 362) in patients with idiopathic congestive cardiomyopathy&#8212;a comparative
study with dobutamine and sodium nitroprusside. <em>J Cardiovasc Pharmacol</em>
1990;16:93&#8211;100.</li>

<li class="Ref">Kramer W, Thormann J, Kindler M, Schlepper M. Effects of forskolin on left
ventricular function in dilated cardiomyopathy. <em>Arzneimittelforschung</em>
1987;37:364&#8211;7.</li>

<li class="Ref">Takeo S, Tanonaka K, Hirai K, et al. Beneficial effect of tan-shen, an extract
from the root of Salvia, on post-hypoxic recovery of cardiac contractile force. <em>Biochem
Pharmacol</em> 1990 40:1137&#8211;43.</li>

<li class="Ref">Bai YR, Wang SZ. Hemodynamic study on nitroglycerin compared with Salvia
miltiorrhiza. <em>Chung Kuo Chung Hsi I Chieh Ho Tsa Chih</em> 1994;14:24&#8211;5 [in
Chinese].</li>

<li class="Ref">Xing ZQ, Zeng XC, Yi CT. Effect of Salvia miltiorrhiza on serum lipid
peroxide, superoxide dismutase of the patients with coronary heart disease. <em>Chung Kuo
Chung Hsi I Chieh Ho Tsa Chih</em> 1996;16:287&#8211;8 [in Chinese].</li>
</ol>
</div>
</body>

<!-- Mirrored from www.naturesbounty.com/vf/healthnotes/HN_Live/Spanish/Es-Concern/Cardiomyopathy.ref.htm by HTTrack Website Copier/3.x [XR&CO'2005], Thu, 03 Mar 2005 14:30:34 GMT -->
</html>

